我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

A Comprehensive Review of Direct Acting Antivirals in Chronic Viral Hepatitis Therapy

Bithonah Prasad

Chronic viral hepatitis is a global public health concern affecting millions of people worldwide. Traditional treatment options for chronic viral hepatitis, including interferon-based therapies, often had limited efficacy and significant side effects. However, the advent of direct acting antivirals (DAAs) has revolutionized the management of chronic viral hepatitis. In this comprehensive review, we provide an overview of the classes of DAAs available for the treatment of chronic hepatitis B and C, highlighting their mechanisms of action, clinical efficacy, safety profiles, and impact on viral clearance. Additionally, we discuss the challenges and future prospects of DAA therapy, emphasizing the potential for achieving sustained virologic responses and eventually eradicating chronic viral hepatitis.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。